Gene therapy for vascular diseases.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Texas Heart Institute Journal

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 8180517PMCID PMC325138
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Systemic gene expression after intravenous DNA delivery into adult mice.

  1993cited by this paper
• Adenovirus-mediated transfer of low density lipoprotein receptor gene acutely accelerates cholesterol clearance in normal mice.

  1993cited by this paper
• Nitric oxide synthase structure and mechanism.

  1993cited by this paper
• Hepatic gene therapy: adenovirus enhancement of receptor-mediated gene delivery and expression in primary hepatocytes.

  1993cited by this paper
• Enhanced prostacyclin synthesis in endothelial cells by retrovirus-mediated transfer of prostaglandin H synthase cDNA.

  1993cited by this paper
• Low Level In Vivo Gene Transfer Into the Arterial Wall Through a Perforated Balloon Catheter

  1992cited by this paper
• In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium.

  1992cited by this paper
• Optimization of retroviral vector-mediated gene transfer into endothelial cells in vitro.

  1992cited by this paper
• Endothelial cells in hemostasis, thrombosis, and inflammation.

  1992cited by this paper
• Percutaneous arterial gene transfer in a rabbit model. Efficiency in normal and balloon-dilated atherosclerotic arteries.

  1992cited by this paper
• Hepatocyte-directed gene transfer in vivo leads to transient improvement of hypercholesterolemia in low density lipoprotein receptor-deficient rabbits.

  1992cited by this paper
• In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors.

  1992cited by this paper
• Long-term expression of human adenosine deaminase in vascular smooth muscle cells of rats: a model for gene therapy.

  1992cited by this paper
• Regulation of PGI2 activity by serum proteins: serum albumin but not high density lipoprotein is the PGI2 binding and stabilizing protein in human blood.

  1991cited by this paper
• Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing.

  1991cited by this paper
• Prostaglandin endoperoxide synthase: structure and catalysis.

  1991cited by this paper
• Direct in vivo gene transfer into the coronary and peripheral vasculatures of the intact dog.

  1991cited by this paper
• Long-term improvement of hypercholesterolemia after ex vivo gene therapy in LDLR-deficient rabbits.

  1991cited by this paper
• TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue.

  1991cited by this paper
• Receptor-mediated gene delivery in vivo. Partial correction of genetic analbuminemia in Nagase rats.

  1991cited by this paper
• Recombinant gene expression in human umbilical vein endothelial cells transduced by retroviral vectors.

  1990cited by this paper
• Trial of iloprost versus aspirin treatment for critical limb ischaemia of thromboangiitis obliterans. The TAO Study.

  1990cited by this paper
• Improved thrombolysis with a modified dose regimen of recombinant tissue-type plasminogen activator.

  1989cited by this paper
• High-level recombinant gene expression in rabbit endothelial cells transduced by retroviral vectors.

  1989cited by this paper
• Seeding of intravascular stents with genetically engineered endothelial cells.

  1989cited by this paper
• Recombinant gene expression in vivo within endothelial cells of the arterial wall.

  1989cited by this paper
• Implantation of vascular grafts lined with genetically modified endothelial cells.

  1989cited by this paper
• Evidence for targeted gene delivery to Hep G2 hepatoma cells in vitro.

  1988cited by this paper
• Receptor-mediated gene delivery and expression in vivo.

  1988cited by this paper
• An alternative approach to somatic cell gene therapy.

  1988cited by this paper
• Primary structure of prostaglandin G/H synthase from sheep vesicular gland determined from the complementary DNA sequence.

  1988cited by this paper
• Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium.

  1987cited by this paper
• Receptor-mediated in vitro gene transformation by a soluble DNA carrier system.

  1987cited by this paper
• Comparative pharmacology of endothelium‐derived relaxing factor, nitric oxide and prostacyclin in platelets

  1987cited by this paper
• Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus.

  1983cited by this paper
• Evidence for a peroxide-initiated free radical mechanism of prostaglandin biosynthesis.

  1980cited by this paper
• Mechanism for irreversible self-deactivation of prostaglandin synthetase.

  1976cited by this paper

• Reciprocal regulation of cyclooxygenase-2 and 15-hydroxyprostaglandin dehydrogenase expression in A549 human lung adenocarcinoma cells.

  2006cites this paper
• Molecular advances in cardiac and cardiovascular disease

  1999cites this paper
• [Thrombosis and tissue protection in microvascular surgery--an overview].

  1997cites this paper
• Gene therapy for transplantation and inflammatory or thrombotic conditions

  1997cites this paper
• Therapie genique utile lors de transplantations et contre les inflammations ou les thromboses

  1996cites this paper
• Amphotropic but not atherotropic: another caveat for adenoviral gene therapy.

  1995cites this paper
• Myocardial revascularization. Historical considerations.

  1994cites this paper